Supernus Pharmaceuticals | SUPN - Marktkapitalisierung

Aktienkurs
48.78
Täglich Wechseln
-0.68 -1.37%
Monatlich
-1.16%
Jährlich
50.14%
Q2 Prognose
48.70




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12